Literature DB >> 8642234

Daytime sleepiness in an adult, Finnish population.

C Hublin1, J Kaprio, M Partinen, K Heikkilä, M Koskenvuo.   

Abstract

OBJECTIVES: To investigate the prevalence of and the factors associated with daytime sleepiness occurring every or almost every day.
DESIGN: A cross-sectional, questionnaire survey.
SUBJECTS: A total of 11,354 adults (aged 33-60 years) representative of the Finnish population. MAIN OUTCOME MEASURES: Frequency of daytime sleepiness, naps and sleep attacks; occurrence of emotion-associated muscle weakness, sleep debt, insomnia, sleep apnoeas and type of snoring; Beck Depression Inventory score; and the use of hypnotics and tranquillisers.
RESULTS: A total of 11.0% of women and 6.7% of men suffered from daytime sleepiness every or almost every day. Amongst those with sleepiness (n = 1,026) 19.5% of women and 42.3% of men reported snoring > or = 3 nights per week, 25% had scores suggesting moderate to severe depression, 11% used hypnotics or tranquilizers on more than 180 days per year, and 9% reported insufficient sleep. Insomnia at least every other day was reported by 20.7% of women and by 28.6% of men. Amongst those with sleepiness, narcolepsy was found in 0.3%, with the diagnosis confirmed in a sleep laboratory evaluation.
CONCLUSIONS: Daytime sleepiness occurring daily or almost daily is most often associated with depression, insomnia and sleep-disordered breathing. In most cases, indications of the cause of sleepiness can be obtained by using simple screening questions.

Entities:  

Mesh:

Year:  1996        PMID: 8642234     DOI: 10.1046/j.1365-2796.1996.475826000.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  29 in total

1.  Sleep disturbances in adult survivors of childhood brain tumors.

Authors:  Vikki G Nolan; Roxanna Gapstur; Cynthia R Gross; Lauren A Desain; Joseph P Neglia; Amar Gajjar; James L Klosky; Thomas E Merchant; Marilyn Stovall; Kirsten K Ness
Journal:  Qual Life Res       Date:  2012-06-06       Impact factor: 4.147

2.  Fatigue in the Danish general population. Influence of sociodemographic factors and disease.

Authors:  T Watt; M Groenvold; J B Bjorner; V Noerholm; N A Rasmussen; P Bech
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

3.  Excessive daytime sleepiness in general hospital nurses: prevalence, correlates, and its association with adverse events.

Authors:  Liping Chen; Chunliu Luo; Shuai Liu; Weiju Chen; Yaping Liu; Yunjia Li; Yun Du; Haihua Zou; Jiyang Pan
Journal:  Sleep Breath       Date:  2018-08-16       Impact factor: 2.816

Review 4.  Mechanisms of reduced sleepiness symptoms in heart failure and obstructive sleep apnea.

Authors:  Victoria M Pak; Lisa Strouss; Henry K Yaggi; Nancy S Redeker; Vahid Mohsenin; Barbara Riegel
Journal:  J Sleep Res       Date:  2018-11-13       Impact factor: 3.981

5.  Endothelial function in patients with post-CPAP residual sleepiness.

Authors:  Ali A El-Solh; Morohunfolu E Akinnusi; Binusha Moitheennazima; Lakshmy Ayyar; Sachin Relia
Journal:  J Clin Sleep Med       Date:  2010-06-15       Impact factor: 4.062

6.  Comparative levels of excessive daytime sleepiness in common medical disorders.

Authors:  Alice F Stroe; Thomas Roth; Catherine Jefferson; David W Hudgel; Timothy Roehrs; Kenneth Moss; Christopher L Drake
Journal:  Sleep Med       Date:  2010-10       Impact factor: 3.492

Review 7.  Sleep disorders and chronic kidney disease.

Authors:  Stephanie C Maung; Ammar El Sara; Cherylle Chapman; Danielle Cohen; Daniel Cukor
Journal:  World J Nephrol       Date:  2016-05-06

8.  Depression: relationships to sleep paralysis and other sleep disturbances in a community sample.

Authors:  Mariana Szklo-Coxe; Terry Young; Laurel Finn; Emmanuel Mignot
Journal:  J Sleep Res       Date:  2007-09       Impact factor: 3.981

Review 9.  From wakefulness to excessive sleepiness: what we know and still need to know.

Authors:  Maurice Moyses Ohayon
Journal:  Sleep Med Rev       Date:  2008-04       Impact factor: 11.609

10.  Treatment of disorders of hypersomnolence.

Authors:  Olufemi Adenuga; Hrayr Attarian
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.